Lung Cancer, Nonsmall Cell Clinical Trial
Official title:
Phase II Study of Induction Platinum Doublet in Combination With Nivolumab Followed by Surgery or Concurrent Chemoradiation in Unresectable Stage IIIA-C Non-small Cell Lung Cancer (NSCLC)
The purpose of this study is to determine the response rate, safety, and effectiveness of a combination therapy in patients with lung cancer.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT06293833 -
Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan
|
N/A | |
| Recruiting |
NCT03705806 -
Palliative Thoracic ImmunoRT
|
||
| Not yet recruiting |
NCT06060964 -
Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management
|
Early Phase 1 | |
| Completed |
NCT04634630 -
The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung
|
||
| Completed |
NCT03689634 -
Move For Surgery - A Novel Preconditioning Program
|
Phase 3 | |
| Recruiting |
NCT05537922 -
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
|
||
| Completed |
NCT03902834 -
Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery
|
N/A | |
| Active, not recruiting |
NCT03322072 -
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating
|
N/A | |
| Completed |
NCT02995889 -
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer
|
N/A | |
| Recruiting |
NCT04237805 -
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
|
Phase 1/Phase 2 | |
| Terminated |
NCT05061940 -
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
|
||
| Recruiting |
NCT05860296 -
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT05863013 -
Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer
|
N/A | |
| Suspended |
NCT02991651 -
Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC
|
Phase 1 | |
| Enrolling by invitation |
NCT04678440 -
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
|
Early Phase 1 | |
| Recruiting |
NCT04222335 -
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients
|
N/A | |
| Recruiting |
NCT04415320 -
X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
|
Phase 2 | |
| Recruiting |
NCT02786589 -
Plasmodium Immunotherapy for Lung Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05085028 -
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
|
Phase 3 | |
| Recruiting |
NCT05956782 -
Breathe Easier II: A Dyad-based Multiple Behavior Intervention
|
N/A |